Women's health used to mean reproductive health. It now takes in cardiovascular disease, autoimmune conditions, mental health, oncology, menopause and healthy ageing. The reasoning is sound. Women experience many conditions differently from men, and that has not consistently been reflected in trial design or treatment development. That gap is not evenly spread, which is the part we hear discussed least.
As pharma and biotech companies manage changing priorities, tight resources and demanding timelines, flexible access to experienced Medical Affairs and Regulatory specialists can provide a practical alternative.
A new report from the ABPI, UK Pharmaceutical Investment Competitiveness Report 2026, concludes that the UK has reversed a long-term decline in pharmaceutical investment. Since September 2025, £2 billion of new investment has been committed to the country, spanning AI-enabled drug discovery through to large-scale manufacturing.
Senior leaders from across the UK pharmaceutical and biotechnology sectors recently came together at PharmaMedic Consultancy's latest executive forum, "Leading Under Pressure: UK Pharma in an AI-Accelerated Era."
PharmaMedic helps generic manufacturers navigate a growing but challenging market. Click to learn more
The life sciences landscape in 2026 is being shaped by a new level of discipline. From AI moving into everyday operations to growing pressure on commercial performance, organisations are balancing innovation with execution. Here are seven key trends defining how in the industry is evolving this year.
At PharmaMedic Consultancy, we offer our specialised services to support healthcare communication agencies in navigating the complexities and challenges that come with delivering compliant and impactful messages in our ever-evolving industry.
We are thrilled to announce a significant milestone in our journey—15 years of dedicated service in the pharmaceutical consulting industry! Thank you to our clients and colleagues for being part of our journey. Here’s to many more years of shared success! Find out more on our service offering.
